Besides, for those subgroups with an increasing trend of outpatient drug costs, other policies are still needed to reduce the financial burden on PD patients, such as promoting the centralized purchasing policy and using generics ( 27 ).
← all excerpts
The impact of China's zero markup drug policy on drug costs for managing Parkinson's disease and its complications: an interrupted time series analysis.
1
—
—